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Regional differences in cardiomyocyte automaticity permit the sinoatrial node (SAN) to function as the
leading cardiac pacemaker and the atrioventricular (AV) junction as a subsidiary pacemaker. The
regulatory mechanisms controlling the distribution of automaticity within the heart are not under-
stood. To understand regional variation in cardiac automaticity, we carried out an in vivo analysis of
cis-regulatory elements that control expression of the hyperpolarization-activated cyclic-nucleotide
gated ion channel 4 (Hcn4). Using transgenic mice, we found that spatial and temporal patterning of
Hcn4 expression in the AV conduction system required cis-regulatory elements with multiple conserved
fragments. One highly conserved region, which contained a myocyte enhancer factor 2C (Mef2C)
binding site previously described in vitro, induced reporter expression speciﬁcally in the embryonic
non-chamber myocardium and the postnatal AV bundle in a Mef2c-dependent manner in vivo.
Inhibition of histone deacetylase (HDAC) activity in cultured transgenic embryos showed expansion
of reporter activity to working myocardium. In adult animals, hypertrophy induced by transverse aortic
constriction, which causes translocation of HDACs out of the nucleus, resulted in ectopic activation of
the Hcn4 enhancer in working myocardium, recapitulating pathological electrical remodeling. These
ﬁndings reveal mechanisms that control the distribution of automaticity among cardiomyocytes during
development and in response to stress.
& 2012 Elsevier Inc. All rights reserved.Introduction
In the vertebrate heart, electrical properties of myocytes are
distributed heterogeneously to optimize contraction and main-
tain electrical stability (Schram et al., 2002). Automaticity, or
spontaneous cellular rhythmicity, is among the most fundamental
of these properties. Although most cardiomyocytes can exhibit
intrinsic rhythmicity under experimental conditions, a negative
gradient of automaticity exists in vivo from sinoatrial (SA) to
atrioventricular (AV) junctional to working myocytes. Underll rights reserved.
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(V. Vedantham),ordinary conditions, the rapid ﬁring rate of SA nodal pacemaker
cells and their efﬁcient coupling to the atrial myocardium ensure
that other potential cardiac pacemakers are silent.
Under abnormal conditions, extranodal areas of the heart exhibit
automaticity. For example, when sinus arrest or heart block occurs, a
subsidiary pacemaker at the atrioventricular junction serves as a
ventricular pacemaker. Within the atria, regions of abnormal auto-
maticity cause ectopic automatic tachycardias or trigger atrial
ﬁbrillation (Roberts-Thomson et al., 2006). The anatomic locations
of ectopic atrial foci are non-random, with clustering in the posterior
right and left atria, AV valvular annuli, pulmonary venous myocar-
dium, coronary sinus myocardium, and near the AV junction (Kistler
et al., 2006). In the ventricles, increased myocardial wall stress,
myocardial hypertrophy, and heart failure lead to aberrant expres-
sion of genes associated with automaticity, creating a vulnerability
to ventricular arrhythmias (Nattel et al., 2007; Stillitano et al., 2008).
The gene regulatory networks that control normal and pathological
variations in automaticity are not well understood.
At the cellular level, automaticity results from interactions among
currents in the plasma membrane and sarcoplasmic reticulum
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diastolic, hyperpolarization-activated inward cation current (funny
current; If) (DiFrancesco, 2010). If is carried by hyperpolarization-
activated, cyclic nucleotide gated-ion channels (Hcn). Of the genes
that encode these channels (Hcn1–4), Hcn4 is the most highly
expressed in cardiac pacemaker tissue and regulates heart rhythm
(Marionneau et al., 2005; Moosmang et al., 2001). Cardiac-speciﬁc
deletion of murine Hcn4 causes embryonic lethality with fetal
bradycardia (Stieber et al., 2003). Postnatal cardiac deletion of Hcn4
by different methods results in bradycardia of varying severity, from
intermittent sinus pauses (Herrmann et al., 2007) to lethal bradycar-
dia with AV block (Baruscotti et al., 2011). In humans, haploinsufﬁ-
ciency of HCN4 causes familial sinus bradycardia (Baruscotti et al.,
2011; Milanesi et al., 2006). In addition to its role in sinoatrial
automaticity, Hcn4 is expressed at the AV junction, where it regulates
junctional pacemaker activity and AV conduction (Yamamoto et al.,
2006). Hcn4 is also expressed in the inter-atrial groove and tricuspid
annulus, and If is an important determinant of ectopic atrial rhythms
that arise from these tissues (Shinohara et al., 2010; Yamamoto
et al., 2006).
Understanding how regional expression of Hcn4 is controlled
during development and in postnatal life would provide insight
into the mechanisms of normal and abnormal automaticity. While
previous studies have identiﬁed a few direct regulators of Hcn4
transcription using primarily cultured cells, including Sp1, NRSF,
Mef2, and AP-1 (Kuratomi et al., 2007, 2009; Lin et al., 2009), it
remains unclear how these widely expressed factors determine
the highly patterned in vivo cardiac distribution of Hcn4.
The complexity of Hcn4 expression is one of many examples of
ﬁne patterning of gene expression in the heart. In several animal
model systems, regionally and temporally restricted gene expres-
sion is controlled by conserved non-coding cis-regulatory ele-
ments (CREs) that activate or repress transcription when bound to
speciﬁc combinations of activated transcription factors (Davidson,
2006). Functional analysis of CREs outside of their native genomic
context has been fruitful for understanding regulatory hierarchies
among cardiac transcription factors during development and for
understanding how core cardiac structural and contractile pro-
teins are transcriptionally regulated (Olson, 2006; Srivastava,
2006). However, it has been difﬁcult to identify and validate CREs
that control gene expression in subsets of functionally specialized
cardiomyocytes as occurring in the cardiac conduction system. In
recent years, just one AV node CRE has been cloned and char-
acterized (Munshi et al., 2009), a few enhancers with activity in
the AV bundle and Purkinje Fibers have been described (Arnolds
et al., 2012; Moskowitz et al., 2007; van den Boogaard et al.,
2012), and no autonomous CREs with speciﬁc activity in the SA
node have been identiﬁed, despite the functional importance of
these structures, their unique patterns of gene expression, and
numerous attempts (Stroud et al., 2007; Viswanathan et al.,
2007). The difﬁculty in identifying CREs that recapitulate highly
patterned gene expression may reﬂect a requirement for multiple
interacting CREs.
To understand how regional variation of cardiac automaticity
occurs in vivo, we investigated deeply conserved non-coding
genomic regions around the Hcn4 locus, each containing pre-
viously identiﬁed transcription factor binding sites (TFBS). Each
region was tested in vivo with a mouse transgenic enhancer–
reporter assay. We found that a 5.7 kb region within the ﬁrst
intron of Hcn4 could direct reporter expression to areas of non-
chamber myocardium in the developing heart, and to the AV
junctional pacemaker in the postnatal heart. A deletion analysis
revealed that two conserved domains from within this region
were sufﬁcient for enhancer activity. One of these domains
contained a conserved Mef2 site, previously described in-vitro,
that was essential for enhancer activity. The enhancer exhibitedsteep dosage-dependence on Mef2C levels during development, and
displayed ectopic activity in ventricular chamber myocardium in
response to HDAC inhibition and pathological stress. Taken together,
our ﬁndings demonstrate that regional variation of Hcn4 expression
is achieved, in part, through modular CREs whose output is
dependent on the actions of signal-responsive transcription factors.Methods
In-Situ Hybridization
A probe corresponding to amino acids 400–690 of mouse Hcn4
was cloned using PCR from mouse heart cDNA. RNA probe was
generated by in-vitro transcription in the antisense direction,
followed by labeling with the DIG RNA labeling kit (Roche).
Embryos were ﬁxed in 4% PFA, washed in PBS, permeabilized in
PBS with 0.3% Triton (PBS.3), brieﬂy treated with 20 mg/mL
proteinase K, and post-ﬁxed. Embryos were then incubated in
pre-hybridization buffer (50% formamide, 4x SSC, 1x Denhardt’s
solution, 0.5 mg/mL salmon sperm DNA, 0.25 mg/mL yeast tRNA,
50 mg/ml heparin)/50% PBS.3 for 3 h at 64 1C. Labeled probe was
added to pre-hyb buffer at 1 mg/mL and incubated with embryos
at 64 1C overnight. Embryos washed with post-hybridization
buffer (50% formamide, 4x SSC, 1x Denhardt’s solution) at 64 1C
for 2 h, followed by PBS.3 at room temperature. Embryos were
then incubated in 2% blocking reagent (20 mM maleic acid,
30 mM NaCl, and 2% BM blocking agent in PBS.3) at room
temperature before application of anti-DIG antibody (1:2000).
Embryos were developed in BM Purple for several hours before
post-ﬁxing and photography.
Mouse transgenesis
Constructs were generated by PCR ampliﬁcation of putative
enhancer regions from a bacterial artiﬁcial chromosome contain-
ing the HCN4 genomic locus (BAC clone RP23-414K12, BACPAC,
CHORI). Primers and genomic coordinates of putative enhancer
regions are given in the Supplementary Table. Putative enhancer
elements were cloned into the reporter vector pKS-hsp68LacZ
(Kothary et al., 1989) by standard methods. DNA for injection was
prepared from linearized enhancer–reporter constructs. The DNA
was isolated on an agarose gel, puriﬁed with an ion exchange
column (Elutip), ethanol precipitated, and taken up in 10 mM
Tris–HCl, 0.1 mM EDTA (pH 8.0) at a concentration of 2 ng/mL
before pronuclear injection by the Gladstone Transgenic Core
Facility. FVB/N mice were used for all transgenesis assays.
Founders were maintained on the FVB/N background, except
when crossed to Mef2Cþ / animals, which were on a C57BL6
background. Mef2ctm1Eno (hereafter, Mef2Cþ /) mice were gener-
ated by Eric Olson (UT Southwestern) and were kindly provided
by Brian Black (UCSF) (Lin et al., 1997).
Histology
Embryos or hearts were collected in cold PBS, ﬁxed for 1 h in
formalin, and stained at room temperature overnight with X-gal or
bluo-gal staining solution (inmM): 5 potassium ferricyanide, 5 potas-
sium ferrocyanide, 2 MgCl2, and 1 mg/ml X-gal or bluo-gal in PBS.
Adult hearts were bisected before staining to facilitate access of the
staining solution to the endocardial side of the heart. Embryos or
hearts were then washed with PBS and post-ﬁxed in formalin. Some
embryos and hearts were dehydrated in methanol and cleared
with a solution of 2:1 benzyl alcohol and benzyl benzoate before
photography. Another group of embryos and hearts was embedded
in parafﬁn, sectioned, and stained with either hematoxylin–eosin,
V. Vedantham et al. / Developmental Biology 373 (2013) 149–162 151Masson’s trichrome, or for acetylcholinesterase activity by standard
methods. A third group of embryos and hearts was processed for
immunohistochemistry after whole-mount bluo-gal staining.
Immunohistochemistry
Embryos or heart samples were ﬁxed in 4% PFA, washed with
PBS, and incubated in 30% sucrose before embedding in OCT for
sectioning. A subset of hearts was already stained with bluo-gal
before embedding in OCT. Sections were permeabilized with 0.3%
Triton X-100, blocked with 10% normal goat serum, and incubated
with primary antibody for Hcn4 (rabbit polyclonal, Alomone labs
APC-052, 1:200), Connexin-43 (rabbit polyclonal, Sigma-Aldrich
SAB4501173, 1:250), Connexin-40 (rabbit polyclonal, Alpha Diag-
nostics CX40-A, 1:200), or beta-Galactosidase (chicken polyclonal,
AbCam ab9361, 1:200) overnight at 4 1C. Slides were washed,
incubated for one hour with the secondary antibody before
mounting in Vectashield with DAPI (Vector Laboratories).
Optical projection tomography
Samples to be imaged were embedded in agarose blocks and
mounted, dehydrated with methanol, cleared with 2:1 benzyl
alcolol:benzyl benzoate, and imaged with an optical projection
tomography scanner according to the manufacturer’s instructions
(Bioptonics, MRC Technology, Edinburgh, UK). Image processing
and 3D reconstruction was performed with NR Recon (Biop-
tonics). Videos were created with Amira (Visage Imaging).
Luciferase assays
Human embryonic kidney cells (HEK-293 T) were transfected
with lipofectamine reagent (Invitrogen) with 50 ng of transcrip-
tion factor, 100 ng of luciferase reporter vector, and 10 ng of
Renilla per well for each well of a 70% conﬂuent 12-well tissue
culture plate. Lipofectamine was removed after 4 h, and for
experiments involving MC1568, either MC1568 (ﬁnal concentra-
tion 4 mM) or vehicle (DMSO) was added after removal of
transfection agent. The cells were lysed 24 h after transfection,
and luciferase activity was measured using Dual-Luciferase
Reporter Assay Kit (Promega).
Electromobility shift assays
Fluorescently labeled oligonucleotides were obtained from
Integrated DNA Technologies, and diluted to 1 mg/mL. Oligos
were incubated at 90 1C for 10 min, 65 1C for 10 min, 37 1C for
10 min, and 22 1C for 10 min. Mef2C protein was made using the
TNT T7 Quick Coupled Translation/Transcription Kit (Promega).
Samples were prepared using an EMSA Accessory Kit (Novagen),
then run on a 10% acrylamide (20:1), non-denaturing 0.5x TBE gel
which contained 0.1% APS and 0.04% TEMED.
Mouse organ culture
Embryos were harvested at E11.5 and were dissected in a 1:1
mixture of F12/Ham’s media at 4 degrees. Hearts were removed
from embryos with attachments to the torso intact and placed in
pre-warmed DMEM/1%FBS at 37 1C. Trichostatin-A (10 mM in
DMSO) or DMSO alone were added 2 h later, and embryos were
incubated for 48 h prior to ﬁxation and staining.
Quantitative PCR
Hearts were dissected in nuclease-free PBS and homogenized
in Tri-Reagent (Invitrogen) with a bead homogenizer (BulletBlender, Next Advance). Total RNA was prepared from the aqu-
eous fraction by isopropanol–ethanol precipitations. Quantiative
PCR was performed on an Applied Biosystems 7900HT machine
with the Taqman system (Applied Biosystems).Thoracic aortic constriction
TAC was performed as described with minor modiﬁcations
(Tarnavski et al., 2004). Adult R2R3LacZ mice were anesthetized
with isoﬂurane, intubated endotracheally and mechanically venti-
lated. TAC was performed through a 0.5 cm incision over the left
thorax via a mediastinal approach. A silk suture was tied around a
27-guage needle positioned adjacently to the aorta. Successful TAC
was conﬁrmed by Doppler measurement of pressure gradient 10
days after surgery. A VisualSonics small animal echo machine was
used to obtain short-axis, M-Mode and Doppler images on sham-
operated and post-TAC R2R3LacZ adult mice. Pressure gradients
were calculated according the modiﬁed Bernoulli’s equation as 4v2,
where v is the blood velocity as determined by continuous wave
Doppler. Parameters were averaged for each genotype, and com-
parisons were made with Student’s T-tests on two independent
samples assuming a two-tailed distribution for each parameter.Results
Expression pattern of Hcn4
The expression patterns of Hcn4 during cardiac development
and in the postnatal heart have been described, with several
previous studies including areas outside the SAN and AVN
(Aanhaanen et al., 2010; Garcia-Frigola et al., 2003; Herrmann
et al., 2011; Yamamoto et al., 2006; Yanni et al., 2009). We used
whole-mount in situ hybridization and immunohistochemistry at
several developmental stages to characterize Hcn4 expression
throughout the heart. Hcn4 was highly expressed in the sinus
horns at embryonic day (E) 8.5 with a negative gradient extending
to the arterial pole of the heart (Fig. 1A). More complex patterning
developed between E9 and E11, with high expression in the sinus
horns and left ventricle, lower expression in the inner curvature
of the AV canal and posterior atria, and trace expression in the
anterior atrium, right ventricle and outﬂow tract (Fig. 1B–F). By
mid-development (E11–E13) Hcn4 was highly expressed in the
right sinoatrial region and sinus venosus contribution to the atria.
There was lower level expression in the ventricles, concentrated
at the crest of the interventricular septum (Fig. 1G–I, Fig. S1A).
Hcn4 expression in several of the areas outside the sinus node was
maintained in postnatal animals, including the sinus venosus
derivatives (coronary sinus and posterior atria), the atrioventri-
cular conduction axis, the tricuspid annulus, and at lower inten-
sity within the His-Purkinje system (Fig. 1J–L, Fig. S1B). Although
cardiomyocytes in these areas have distinct developmental ori-
gins, they are often grouped together as non-chamber myocar-
dium to distinguish them from the working myocardial cells,
whose primary role is force generation. We found that, within the
non-chamber myocardium, Hcn4 expression was highly pat-
terned, with the following negative gradient: SA node4posterior
atrium/atrial septum4AV node and nodal extensions4AV bun-
dle4 infra-nodal ventricular conduction system. Within the
working myocyte compartment, Hcn4 expression waxes in early
and mid-development before waning in late development. This
expression pattern correlates well with established differences in
automaticity among different subsets of cardiomyocytes, and
suggests a complex cis-regulatory architecture for patterning of
automaticity in the heart.
Fig. 1. Expression pattern of Hcn4 mRNA by whole-mount in-situ hybridization. (A) At E8.5, Hcn4 was expressed throughout the heart tube in a caudal-to-cranial gradient.
By E9.5 (B,C), expression was less in the atrial chamber, right ventricle (rv), and outﬂow tract (oft) than in other areas. At E10.5 and E11.5 (D–H), Hcn4 was strongly
expressed in the sinus venosus (sv) and its interface with the atria, and at lower levels in the atria and ventricles. At E12.5 (I), Hcn4 was expressed highly in the sinoatrial
node, the sinus venosus contribution to the atria including the coronary sinus (cs), and at lower levels in the ventricles and right atrium. In the neonatal heart (J,K), Hcn4
was expressed in the SA node, the sinus venosus derivatives, and the AV ring tissue. In (L) the ventricles are shown after clearing. A low-intensity meshwork of staining is
visible, consistent with the His-Purkinje system (arrowheads delineate an example of a Purkinje ﬁber strand in the left ventricle). Abbreviations: ra, right atrium; la, left
atrium; v, ventricle; rv, right ventricle; lv, left ventricle; sh, sinus horns; sv, sinus venosus oft, outﬂow tract; cs, coronary sinus.
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to the heart
To identify conserved regions that might serve as CREs at the
Hcn4 locus, we used the ECR Browser, an online multispecies
sequence alignment tool (Fig. 2B) (Ovcharenko et al., 2004). The
basal promoter and transcriptional start site of murine Hcn4 have
been deﬁned (Kuratomi et al., 2009), as have transcription factor
binding sites (TFBS) located in intron 1 for Mef2, AP-1, and NRSF
(Fig. 2B). Deeply conserved putative CREs were deﬁned as
segments of at least 100 bp of non-coding genomic DNA with
greater than 70% sequence homology among mouse, human, and
opossum genomes (Fig. 2B). We deﬁned ﬁve genomic regions of at
least 2 kb (Promoter region, R1–R4), each anchored by at least one
deeply conserved segment. R1–R4 or the promoter region was
each individually cloned from an Hcn4-containing BAC into either
the basal promoter-containing hsp68LacZ reporter vector or
directly upstream of LacZ (Supplementary Table). Enhancer–
promoter–reporter constructs were linearized and injected into
pronuclei of fertilized ova (Fig. 2A). The ova were implanted
and founder embryos were harvested at E11.5 for staining with
bluo-gal. At least 3 transgenic founders were examined for each
construct. None of the constructs exhibited a consistent androbust pattern of reporter gene expression within the heart,
indicating that none of these elements were sufﬁcient to drive
Hcn4 expression in the embryonic heart (Fig. 2B, Supplementary
Table). To test whether larger genomic regions were required for
enhancer activity, we investigated combinations of regions,
beginning with R2 and R3 (a 5.7 Kb contiguous piece of genomic
DNA). In 12 of 13 R2R3-LacZ founder embryos, a consistent
pattern of reporter activity at E11.5 was observed in discrete
areas of the heart. While there was variability in overall intensity
and in the extra-cardiac staining among founder embryos (reﬂect-
ing different genomic integration sites), each of the founders
exhibited reporter activity in a consistent pattern within the
sinoatrial region, AV canal, and within the ventricles (Fig. 2C).
Hcn4-R2R3 enhancer activity during development
To characterize R2R3 activity in detail, we performed whole
mount bluo-gal staining at several stages in two mouse lines
derived from different R2R3-LacZ founder animals. Both lines
exhibited the same spatiotemporal pattern of reporter activity
in speciﬁc subdomains of the heart, but differed in the intensity
of cardiac reporter activity and in extra-cardiac activity, reﬂect-
ing distinct genomic integrations sites and likely a different
Fig. 2. Identiﬁcation and in vivo testing of Hcn4 regulatory elements. (A) Genomic regions containing putative CREs were cloned upstream of hsp68LacZ or LacZ
(basal promoter) to generate constructs for pronuclear injection. (B) Three species alignment at the Hcn4 locus from the ECR Browser, with mouse as the base genome against
human and opossum. Peaks reﬂect degree of conservation (scale: 50–100%). Color code: red, upstream non-coding DNA; salmon, intronic DNA; blue, exons. Multiple conserved
elements were selected for analysis (1–4) from Intron 1. Locations of previously validated transcription factor binding sites (TFBS) are indicated (NRSF, Mef2, AP-1, Sp1). Examples of
founders from each construct injected are shown below the corresponding area on the Hcn4 genomic map. Although the presence of variable extra-cardiac reporter activity among
different founders conﬁrmed reporter insertion into permissive loci, none of the founders exhibited consistent reporter activity within the heart. (C) Left, an E11 embryo from an
R2R3-LacZ transgenic line (line 17) stained with bluo-gal reporter activity within deﬁned areas of the heart. Right, the cardiac region of line 17 in comparison with embryos from two
additional transgenic founders (line 15 and line 22) shows similar cardiac reporter activity despite different genomic integration sites. By whole mount imaging, activity is
concentrated at the junction of the sinus venosus and the right atrium, a linear area extending from the sinus venosus at the level of the interatrial groove to the ventricles (arrow),
and within the ventricles. Sections from one founder embryo (line 15, bottom left) show reporter activity in the interventricular ring at the crest of the developing interventricular
septum (section 1); and between the sinus venosus and atrium (section 2). Abbreviations: sv, sinus venosus; ra, right atrium; la, left atrium; v, ventricles; rv, right ventricle; lv, left
ventricle. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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inﬂow tract, caudal and posterior heart tube, and AV canal at
E8.5 (Fig. S2). By E11.5, activity was detected only in non-
chamber myocardium: the right venous valve, AV canal, poster-
ior atrium, primary atrial septum, and crest of the developing
interventricular septum (Fig. 3A–C; Video 1). By E15.5, there
was less activity in atrial non-chamber regions, while
high-level expression was preserved within the developing AV
conduction system (Fig. 3D–F; Video 2). This pattern persisted
in neonatal hearts, with loss of activity in atrial non-chamber
myocardium and preserved expression in the AV conduction
system (Fig. 3G–I). Hcn4 is expressed in all of these areas,
indicating that R2R3 recapitulates the non-SA nodal, non-
chamber myocardial component of the Hcn4 developmental
expression pattern. Mutual exclusion of b-gal activity and
expression of connexin-43 (Cx43), a marker of the chamber
myocardium, conﬁrmed restriction of enhancer activity to thenon-chamber myocardium at E11.5 (Fig. 3J,K) and at E15.5
(Fig. 3L,M).
Hcn4-R2R3 enhancer activity in the postnatal and adult heart
In the postnatal heart, R2R3 activity persisted in a continuous
region extending from the interface of the compact AV node
with the AV bundle (lower nodal cells) to the terminal portion of
the AV bundle itself (Video 3). Expression was no longer present
in the atrial non-chamber myocardial derivatives. As animals aged,
the speciﬁcity of activity persisted with the AV bundle, but the
intensity of activity gradually diminished into adulthood.
Serial sections at the adult AV junction showed that expression
was conﬁned to the AV bundle/lower nodal cell (AVB/LNC) compart-
ment, as evidenced by anatomic location of reporter activity
and the presence of insulating ﬁbrous tissue around b-gal positive
cells (Fig. 4A–F). The AVB/LNC is a single transcriptional domain
Fig. 3. In vivo temporal reporter activity directed by the combined R2-R3 Hcn4 enhancers. A stable transgenic R2R3-LacZ mouse line was examined at E11.5 (A–C), at
E15.5 (D–F) and at the neonatal stage (G–I). At E11.5, a whole mount bluo-gal stained embryo (A) and parafﬁn sections of bluo-gal stained embryos counterstained with
nuclear fast red (B,C) showed reporter activity in the non-chamber embryonic myocardium including the AV canal, the interventricular ring at the crest of the developing
interventricular septum, the posterior atrium/interatrial groove and right venous valve. At E15.5 (D–F), expression was conﬁned to the atrial non-chamber myocardium
and the developing AV conduction system. By late development, only faint expression was visible in atrial non-chamber myocardium while more robust expression was
present within the AV conduction system (G–I). Of note, high-level activity was never noted in the SAN primordium or the perinatal SAN, indicating that R2R3 is not
sufﬁcient to direct expression to this tissue. Immunohistochemistry for Cx43, marking chamber myocardium, on bluo-gal stained cryosections (bottom row) showed
mutual exclusion of Cx43 and b-gal activity in the ventricles at E11.5 (J,K) and at E15.5 (L,M). Abbreviations: san, sinoatrial node; avc, atrioventricular canal; rvv, right
venous valve; pas, primary atrial septum; ra, right atrium; rv, right ventricle; ivs, interventricular septum; avn, atrioventricular node; avb, atrioventricular bundle; av ring,
atrioventricular ring; a, common atrium; ivr, interventricular ring.
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of connexin-40 (Cx40) and from working ventricular myocytes
by the absence of connexin-43 (Cx43) (Aanhaanen et al., 2010).
Immunohistochemistry for Cx43, Cx40, and b-gal at the AV
junction of R2R3-LacZ adults, by which point enhancer activity had
diminished in intensity, revealed persistent overlap between b-gal
and Cx40 but mutual exclusion of b-gal and Cx43, conﬁrming
restriction of enhancer activity to the AVB/LNC into adulthood
(Fig. 4G–I).Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2012.10.017.
A minimal cis-regulatory element contains two deeply conserved
regions
To deﬁne the minimal regulatory element capable of recapitulat-
ing the R2R3 pattern of enhancer activity, we performed a deletion
analysis (Fig. 5A). While much of R2 and R3 could be deleted without
Fig. 4. In vivo expression directed by the R2R3 Hcn4 enhancer in the post-natal AV bundle and its interface with the AV Node. (A–E) A postnatal (P5) R2R3-LacZ heart was
stained with bluo-gal, imaged with optical projection tomography in whole-mount, then sectioned and counterstained with hematoxylin-eosin. (A) An image from a 3D
reconstruction of optical projection tomograms shows a discrete band of enhancer activity along the anterior-posterior axis of the AV junction. Dashed lines indicate the
positions of the coronal sections shown in panels B-E proceeding from anterior-posterior (1–4). The band of reporter activity begins below the annulus ﬁbrosis (af)
anteriorly at the crest of the interventricular septum (ivs) just below the aortic valve (ao) (B). As it moves posteriorly (C,D) expression band proceeds superiorly and
penetrates the af, eventually terminating within it. In section 4 (E), the solid black line demarcates the area of the compact atrioventricular node (cavn)þ inferior nodal
extension (ine) and the solid white line demarcates the atrioventricular bundle (avb)þ lower nodal cells (lnc) where reporter activity was present. (F) Post-natal hearts
were also sectioned and counterstained with trichrome to visualize ﬁbrous tissue (light blue). A close-up view of the area of bluo-gal is shown to contain abundant
insulating collagen ﬁbers (light blue), consistent with its identity as the avb. (G,H) Immunohistochemical analysis of an R2R3-LacZ section from an adult heart at the level
of the avb (outlined, dashed line) showed mutual exclusion of b-gal and Cx43, but co-expression of b-gal and Cx40 in the avb. (I) A more posterior section at the level of the
cavn (outlined, solid white) showed b-gal expression within the Cx40þ lnc domain (outlined, dashed line) that comprises the interface between the avb and the avn.
Abbreviations: A, anterior; P, posterior; Cr, cranial; Ca, caudal; lv, left ventricle; ra, right atrium; rv, right ventricle; tv, tricuspid valve; mv, mitral valve. (For interpretation
of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
V. Vedantham et al. / Developmental Biology 373 (2013) 149–162 155affecting reporter activity, deletion of either of the most conserved
segment of R2 or of R3 dramatically reduced reporter activity
(Fig. 5B, constructs 2–5) as compared to the full-length construct
(Fig. 5B, construct 1). The only deletion constructs that preserved
enhancer activity speciﬁcally within the non-chamber myocardium
of both atria and ventricles contained the two most highly con-
served segments (Fig. 5B, constructs 6–8), demonstrating that thepresence of both conserved regions was necessary and sufﬁcient for
the full extent of reporter activity.
Hcn4-R2R3 activity requires a conserved Mef2 site
A conserved and functional Mef2 site in R3 has been well-
characterized in vitro using binding assays and rat neonatal
Fig. 5. Identiﬁcation of minimal enhancer regions within R2R3 that direct reporter activity in the Hcn4 expression domain. (A) A deletion analysis of R2R3-LacZ revealed
that only constructs bearing both deeply conserved sequences could direct robust reporter expression to the atrial and ventricular nonchamber myocardium at E11.
(B) Representative examples of E11 founder embryos from each construct is shown after bluo-gal staining and imaging of the heart in whole mount from the right side.
A diagram is shown at the top left depicting the heart region. The pattern of full-length R2R3-LacZ is shown for comparison as construct 1. Of the deletion constructs tested
that did not contain both conserved sequences (constructs 2–5), only construct 2 had some cardiac activity in atrial non-chamber myocardium in 2/5 embryos (D).
In contrast, those with both conserved regions (constructs 6–8, bottom row) did preserve the activity of full length R2R3. The minimal enhancer capable of reconstituting
the entire expression pattern of the full-length sequence, construct 8, consisted of the two conserved regulatory elements (light blue) without intervening sequence.
Abbreviations: p, promoter; sv, sinus venosus; ra, right atrium; v, ventricle; oft, outﬂow tract; lb, limb bud; pa, pharyngeal arch; ‘‘þþ’’ denotes robust and consistent
activity, ‘‘þ ’’ denotes inconsistent or low-level activity. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
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expressing a dominant negative form of Mef2 have reduced levels
of If and Hcn4. We therefore hypothesized that the previously
characterized Mef2 site in R3 might be critical for activity of our
enhancer. We ﬁrst conﬁrmed that the Mef2 site efﬁciently binds
Mef2C transcription factor using an electromobility shift assay
(EMSA) (Fig. S3A). To conﬁrm the site is functional, we tested the
ability of Mef2C conjugated to VP-16 to regulate R3-dependentluciferase activity. In HEK-293T cells, we observed robust activa-
tion of R3-luciferase by MEF2C-VP16 that was predominantly
dependent on the conserved Mef2 site (Fig. S3B).
Since Mef2C is widely expressed throughout the embryonic
heart, it is not clear how this site might regulate the dynamics of
Hcn4 expression in vivo. Of the four Mef2 isoforms expressed in
the heart, Mef2C predominates in the developing heart and
declines relative to Mef2A and Mef2D after birth (Edmondson
Fig. 6. Mef2C regulates R2R3 Hcn4 enhancer activity via a conserved Mef2 Site.
(A) Top, a conserved binding site for Mef2 was present within R3 as shown by an
alignment between homologous regions of mouse, human, and opposum genomic
DNA. Mismatches, shown in red, were not predicted to prevent Mef2 binding.
Bottom, the Mef2 site in R3 was mutated at sites required for binding (mutations
in red). (B) Transient R2R3-LacZ transgenic embryos bearing the Mef2 binding site
mutation lost cardiac reporter activity. A founder bearing the unmutated R2R3 is
shown for comparison (top left). Non-speciﬁc extracardiac ectopic activity con-
ﬁrmed transgene insertion into a permissive locus in the three founder embryos
shown that bear the mutated Mef2 site in the context of R2R3. (For interpretation
of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
Fig. 7. Mef2C regulates R2R3-LacZ and Hcn4 expression in vivo. E11.5 embryos (A,C)
and embryonic hearts (B,D) from Mef2Cþ /;R2R3-LacZ compound heterozygous mice
after whole-mount bluo-gal staining. Mef2Cþ / embryos (C,D) had reduced cardiac
staining. At E16.5, the AV junction region of Mef2Cþ / hearts (G) had reduced reporter
activity compared toWT (E). (F,H) show higher magniﬁcation of the AV junction region.
Immunohistochemistry for Hcn4 at the AV junction showed a moderate reduction in
Hcn4 expression in Mef2Cþ / embryos (J) compared toWT (I) at E16.5. The AV bundle
is outlined (dashed line). Abreviations: avb, atrioventricular bundle; ra, right atrium; la,
left atrium; rv, right ventricle; lv, left ventricle.
V. Vedantham et al. / Developmental Biology 373 (2013) 149–162 157et al., 1994). We tested the importance of the Mef2 site in-vivo by
mutating it in the context of full-length R2R3-LacZ. We found a
loss of cardiac enhancer activity in four out of four transgenic
founder embryos at E11.5 (Fig. 6A,B). The presence of extra-
cardiac but not cardiac activity in these founders demonstrates
insertion of the transgene into a permissive genomic locus and
the importance of the Mef2 site for cardiac activity. To
test whether R2R3 is regulated by Mef2C in vivo, we crossed
R2R3-LacZ mice with Mef2C heterozygotes (Mef2Cþ /). While
the reporter expression pattern was preserved in the R2R3-
LacZ;Mef2Cþ / animals, the intensity of cardiac reporter activity
was reduced in the nonchamber myocardium in all embryos
examined (3 separate litters) as compared to R2R3-LacZ litter-
mates, conﬁrming sensitivity of enhancer activity level to Mef2C
dosage at E11.5 (Fig. 7A–D). This experiment was repeated in an
R2R3-LacZ line with extensive extra-cardiac positional activity as
well as activity in the nonchamber myocardium. Each of the
Mef2Cþ / embryos from this cross showed less cardiac reporter
activity than WT, while the extra-cardiac activity was unchanged,
conﬁrming the speciﬁcity of the Mef2C dosage dependence
(Fig. S4). At E16, R2R3-LacZ;Mef2Cþ / hearts had less reporter activityin the AVB/LNC, indicating thatMef2C dosage sensitivity persisted late
into development (Fig. 7E–H). Immunohistochemistry at the AV
junction showed less Hcn4 expression in Mef2Cþ / hearts at E16
(Fig. 7I,J), conﬁrming the relevance of our enhancer ﬁndings to Hcn4
gene expression.
HDAC activity regulates the spatial extent of enhancer activity
Having established that Mef2C regulates the intensity of
enhancer activity within the nonchamber myocardium, we
explored two possible mechanisms that might explain the spatial
V. Vedantham et al. / Developmental Biology 373 (2013) 149–162158restriction of enhancer activity to the nonchamber myocardium
and AV bundle.
First, we sought to identify factors that might activate R2 in
the nonchamber myocardium by searching for conserved TFBS
within its most highly conserved segment. Using the MULAN
multiple alignment tool and the RVISTA database of transcription
factor position weight matrices, we identiﬁed several conserved
putative TFBS for factors known to regulate development of the
AV conduction system, including Gata, Nkx2.5, and Smad proteins.
In addition, an E-box consensus site and a highly conserved
consensus site for the downstream mediators of hedgehog signal-
ing, Gli, were also identiﬁed. Each of these sites was mutated
either singly or in tandem within R2R3. Although some alterations
in the intensity of enhancer activity were observed with tandem
mutation of Smad and Gli sites, and with mutation of the E-box
site (Fig. S5), none of the mutants completely abrogated enhancer
activity at E11.5 across multiple founders. This ﬁnding suggests
redundancy in function of these sites or that these sites are not
relevant to enhancer activity at E11.5.
An alternative hypothesis is that domain restriction of R2R3
occurs in part by differential signaling to Mef2 within the non-Fig. 8. HDAC Activity Regulates Hcn4 R2R3. (A) MEF2C-VP16 was co-transfected with W
(DMSO) vehicle was added after transfection. Relative luciferase activity (RLA) was norm
in the absence of MC1568. Means were compared with two-tailed t-tests (n, po0.05; n
hearts that were cultured for 48 h in 10 mM Trichostatin-A (TSA) or DMSO. (D,E). Imm
exposed cultured E11.5 embryonic hearts. R2R3-LacZ embryonic hearts exposed to
expression.chamber myocardium. Signal-responsiveness of Mef2-dependent
transcriptional activity in cardiomyocytes depends on the activity
of Class IIa HDAC proteins (Lu et al., 2000). We used the selective
class II HDAC inhibitor MC1568 to test the Mef2 site in R3 for
signal responsiveness in vitro using HEK cells. Transactivation of
R3 by MEF2C-VP16 was augmented by MC1568, an effect that
was abrogated by mutation of the Mef2 site (Fig. 8A). To
determine whether differences in HDAC activity among chamber
and non-chamber myocytes might contribute to the spatial
restriction of R2R3 activity, we cultured R2R3-LacZ embryonic
hearts and exposed them to HDAC inhibition. Because of limited
solubility of MC1568, we used a less selective HDAC inhibitor
with greater solubility, Trichostatin-A (TSA), for organ culture
experiments. Embryos were cultured for 48 h, and then were
stained with bluo-gal to assess enhancer activity. We found a
striking expansion of enhancer activity in cultured embryonic
hearts exposed to TSA as compared to the hearts exposed
to DMSO (Fig. 8B,C). To test whether Hcn4 expression was
similarly affected, we performed immunohistochemistry for
Hcn4 in these hearts, and found increased Hcn4 expression
associated with HDAC inhibition (Fig. 8D,E). Taken together, theseT R3-Luc or MT R3-Luc. The Class II HDAC inhibitor MC1568 or dimethyl sulfoxide
alized to the value obtained with co-transfection of WT R3-Luc and empty pcDNA1
nn, po0.001) (B,C) Whole-mount bluo-gal staining of E11.5 R2R3-LacZ embryonic
unhistochemistry for Hcn4 in cryosections of the left ventricle of TSA or DMSO
TSA showed an expansion of enhancer activity and increased ventricular Hcn4
V. Vedantham et al. / Developmental Biology 373 (2013) 149–162 159results demonstrate that HDAC activity is involved in restricting
the spatial extent of enhancer activity and Hcn4 expression, and is
therefore involved in the patterning of Hcn4 expression in the
developing heart.
Hcn4-R2R3 enhancer is activated ectopically in a model of cardiac
hypertrophy
In human and mouse hearts, Mef2 activity increases with
pathological remodeling, in part because class IIa HDACs are
phosphorylated and exported from the nucleus in response to
stress. In light of the HDAC responsiveness of R2R3 in-vitro and ex-
vivo in organ culture, we hypothesized that the domain of R2R3
enhancer activity might expand outside of the AV bundle in
response to stress. To test this hypothesis, six R2R3-LacZ mice
were subjected either to transverse aortic constriction (TAC) or a
sham operation. Development of cardiac hypertrophy in TAC
animals was conﬁrmed by echocardiography 10 days after the
procedure (Fig. 9A and S6). Mice were sacriﬁced, and hearts
stained with bluo-gal or processed for RNA preparation and
quantitative PCR. Nppa expression increased markedly in TAC
hearts, demonstrating activation of stress-responsive gene
expression (Fig. 9B). Bluo-gal staining of TAC hearts showed
dramatic broadening in areas that were subjected to increased
wall stress but not in areas that were relatively protected from
pressure overload (Fig. 9C–F). In contrast, enhancer activity in
sham-operated animals was conﬁned to the AVB/LNC. Thus,
although R2R3 activity is tightly restricted to the AVB/LNC under
normal conditions, stress conditions disrupt this ﬁne patterning,
providing an explanation for ectopic Hcn4 expression under
pathological conditions.Discussion
We investigated mechanisms that control the distribution of
automaticity among cardiomyocytes during development and in
response to stress using an in vivo CRE analysis at the Hcn4 locus.
We found that a 5.7 kb segment of genomic DNA from Intron 1 of
Hcn4 regulates regional expression of Hcn4 in-vivo. Detailed
characterization of this enhancer showed expression restricted
to embryonic non-chamber myocardium and the postnatal AV
bundle. Enhancer activity required the presence of two deeply
conserved fragments from within the full-length segment, one of
which was sensitive to Mef2c dosage in vivo. Enhancer activity
broadened in response to HDAC inhibition in cultured embryos
and in response to a hypertrophic stimulus. Our data suggest that
one mechanism by which regional restriction of Hcn4 expression
to parts of the cardiac conduction system is achieved is through
the HDAC–Mef2 system, and that stress signaling may disrupt this
pathway, leading to pathological electrical remodeling in the
diseased heart.
Hcn4 expression is dynamically patterned during development
We used regional expression level of Hcn4 as a marker for
relative degree of automaticity. Hcn4 in situ hybridization data
conformed to the well-established decreasing gradient of auto-
maticity from sinoatrial to junctional to working myocytes.
Recent studies on Hcn4 expression in avians and in humans
support deep evolutionary conservation of the extranodal Hcn4
gradient (Sizarov et al., 2011; Vicente-Steijn et al., 2011).
Although several studies demonstrate that If is involved in ectopic
and junctional automaticity, the roles of Hcn channels in normal
functioning of the AV junction and other areas have not been
established. Cardiac-speciﬁc deletion of Hcn4 is embyronicallylethal by E11.5, consistent with it playing a critical role in
supporting embryonic cardiac electrical activity. In light of its
wide area of expression during development and under stress,
Hcn4might play an important role in regulating electrical proper-
ties of working myocytes beyond its established role in support-
ing nodal automaticity.
Hcn4-R2R3 activity is restricted to speciﬁc transcriptional domains
Embryonic non-chamber myocardium includes precursors of
the AV conduction system, the valvular annuli, and the interatrial
septum. Myocytes in these areas have distinct gene expression
proﬁles compared to embryonic chamber myocardium
(Aanhaanen et al., 2010; Bakker et al., 2008b). The T-box tran-
scription factor Tbx3 is speciﬁcally expressed in the non-chamber
myocardium and regulates speciﬁcation of the AV conduction
system, largely by repressing the regulatory program of the
working myocardium (Bakker et al., 2008a; Hoogaars et al.,
2007). One paradigm for transcriptional activation in the AV
conduction system is that widely expressed transcriptional acti-
vators such as Nkx2.5, Tbx5, and Gata4, acting in the presence of
repressors of the chamber phenotype such as Tbx3, are sufﬁcient
to generate the phenotypic characteristics of the specialized
conduction tissue (Bakker et al., 2011). In keeping with such a
mechanism, although neither Mef2C expression nor Mef2 activity
is conﬁned to the non-chamber regions during development, we
found that Mef2C-dependent R2R3 activity is restricted to non-
chamber myocardium. R2R3 must, therefore, be under the control
of factors or signaling pathways in addition to Mef2C. Mef2
activity may provide an activating signal by binding to R3, while
other factors restrict the spatial extent of R2R3 activity, possibly
by acting on R2.
The ventricular non-chamber myocardium, located at the crest
of the developing interventricular septum, forms the AVB/LNC.
R2R3 activity localizes to this tissue throughout development and
in the adult heart. In explanted human heart preparations, the
junctional rhythm originates at the interface of the AV node with
the AVB, the area where we observe the highest intensity of
enhancer activity (Fedorov et al., 2011). R2R3 and its upstream
regulator Mef2 are therefore determinants of the unique gene
expression proﬁle of the junctional pacemaker.
Mef2C regulates Hcn4 AV junctional gene expression
Mef2Cþ / animals have no reported phenotype, while Mef2C
knockouts have early embryonic lethality with slow embryonic
heart rate (Lin et al., 1997). Transgenic overexpression of a
dominant negative Mef2 protein causes a reduction in Hcn4 levels
in the embryonic heart (Kuratomi et al., 2009). The Mef2 site
within R3 has been identiﬁed previously, but its speciﬁc in vivo
role could not be deﬁned because R3 did not have autonomous
enhancer activity (Kuratomi et al., 2009). By combining R3 with
other conserved segments, we showed that the Mef2 site has a
role in regulating Hcn4 expression within speciﬁc domains during
development and in the adult heart. Moreover, Mef2C can bind
speciﬁcally to R3, and R2R3 activity was exquisitely sensitive to
Mef2C dosage throughout development.
Mef2 binding sites are widely present on cardiac enhancers
and regulate transcription of many cardiac genes. As suggested
above, Mef2 might regulate spatially restricted R2R3 activity by
interacting with other activators or repressors that are speciﬁc to
the non-chamber myocardium and AVB/LNC. Alternatively, varia-
tions in basal signal strength between the AVB/LNC and working
myocardium might be coupled to gene expression through HDAC-
dependent Mef2 activity. If a basal signal is present in the AVB/
LNC that causes nuclear export of class IIa HDACs, it might
Fig. 9. Hcn4 R2R3-LacZ activity expands in response to ventricular pressure overload. Hcn4 R2R3-LacZ transgenic animals subjected to transverse aortic constriction (TAC)
had 30% greater heart weight to body weight (HW/BW) ratios compared to sham-operated animals (A) and had induction of ANF expression as assessed by quantitative
PCR on whole ventricle RNA (B). Whole-mount bluo-gal staining showed no expansion of enhancer activity beyond the AVB/LNC in the sham-operated animals (C,D),
whereas animals subjected to TAC showed an increase in enhancer activity throughout the subendocardial myocardium of the left ventricle (lv) where pressure load is the
greatest (D,E). By comparison, the right ventricle (rv), which is not pressure-loaded in this experiment, did not show any increase in enhancer activity. Each value is
expressed as mean with error bars denoting standard error of the mean. Means were compared with two-tailed t-tests (n, po0.05; nnn, po0.001). Abreviations: ivs,
interventricular septum; avb, atrioventricular bundle.
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activity of R2R3.
Multiple conserved regions are required to regulate Hcn4 expression
None of the putative Hcn4 CREs we tested were sufﬁcient to
drive reporter expression when tested in isolation. These data
comport with other studies of cardiac CREs, which deﬁned a
strikingly low rate of in vivo validation (2%) for conservation-
based enhancer predictions (Pennacchio et al., 2006; Visel et al.,
2008). This ﬁnding has been taken as evidence of the importance
of weakly conserved CREs in the heart (Blow et al., 2010). An
alternative explanation would be a requirement for combinations
of conserved regions, which would not be detected using standard
methods of in vivo enhancer analysis. Here, we showed that two
spatially separated conserved genomic DNA segments, neither of
which is sufﬁcient to drive gene expression alone, promote
domain-speciﬁc expression when combined, even with the inter-
vening sequence removed. Whether this mechanism can be
generalized to other instances of ﬁne patterning in the heart
remains to be determined.
Although Hcn4 is frequently used as a marker for specialized
conduction tissue in studies of conduction system development
(Aanhaanen et al., 2010), only a few studies explored transcrip-
tional regulation of Hcn4 during development and in heart diseasemodels (Kuratomi et al., 2007; Lin et al., 2009). Sp1, a ubiquitous
transcription factor, is upregulated in cardiomyocytes in response
to stress signaling and has many predicted binding sites in the
core promoter region of Hcn4 that likely regulate Hcn4 expression
(Lin et al., 2009). Although we tested the basal promoter region
and found no evidence of autonomous in-vivo transcriptional
activity at E11.5, TFBS in this region undoubtedly have important
roles in regulating expression both during development and in
response to stress. A binding site has also been deﬁned for the
neuron restricted silencing factor (NRSF) in intron 1 of Hcn4
(Kuratomi et al., 2007). This site is important for repressing
Hcn4 transcription in perinatal ventricular myocardium, and relief
of this repression is required for reactivation of Hcn4 expression
in hypertrophic myocytes. This NRSF site was contained within
R4, a region that did not exhibit autonomous transcriptional
activity, consistent with its postulated role as a repressive
regulatory element. We did not identify a conserved NRSF site
in R2R3. However, the ﬁnding that R2R3 is not active in working
ventricular myocardium under normal conditions but becomes
active after TAC suggests that domain restriction of Hcn4 expres-
sion must be achieved through multiple transcriptional mechan-
isms. With the complexity of the Hcn4 locus, several overlapping
and partially redundant mechanisms are likely required to confer
robustness on the Hcn4 expression pattern, and by extension, the
automaticity gradient.
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In response to physiological signals and pathological stress,
electrical properties of myocytes remodel through mechanisms
that are under intensive investigation (Nattel et al., 2010). In
animal models of heart disease and in human heart failure, Hcn4
becomes active in hypertrophied and failing ventricular myocytes
and may promote arrhythmogenesis (Stillitano et al., 2008). The
responsiveness of R2R3 to TAC led us to examine signaling
pathways that regulate Mef2 activity in pathological ventricular
remodeling. Class IIa HDACs act as transcriptional co-repressors
by binding directly to Mef2 and silencing Mef2-dependent tran-
scription (Haberland et al., 2009). Increased wall stress leads to
nuclear export of class IIa HDACs by a calcium calmodulin kinase
II–dependent pathway (Lu et al., 2000). In both our cell-culture
system and in explanted hearts, we found that HDAC inhibition
potentiates R2R3 activity, one possible explanation for the broad-
ening of R2R3 activity after TAC. Although we did not directly test
for an interaction between HDAC and Mef2 on the R2R3 enhancer
and there are other possible mechanisms that might explain our
ﬁndings, one unifying hypothesis is that activation of Hcn4
expression by Mef2 is regulated by HDAC activity. It will be
interesting to determine if the increased activity of R2R3 in the
setting of cardiac hypertrophy contributes to arrhythmogenicity
by altering the domain of Hcn4 expression, and whether a speciﬁc
interaction between class IIa HDACs and Mef2 directs this
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